Research News From August 28, 2005
advertisement
- Strict Glycemic Control Slashes CVD Risk in Type 1 Diabetes.
- The Effect of Insulin Antibodies on the Metabolic Action of Inhaled and Subcutaneous Insulin.
- What are disease perceptions and subjective treatment goals
of insulin treated diabetic patients? Free full text available in PDF format. - Where is the Cure?
- UCSF drug continues to fend off progression of type 1 diabetes.
- Prevalence of Type 1 diabetes in New Zealanders aged 0-24 years.
- Identifying risk of type 1 diabetes.
- How to make pancreatic beta cells – prospects for cell therapy in diabetes.
- Gastrointestinal stem cells. I. Pancreatic stem cells.
- Differentiation of Human Liver-Derived, Insulin-Producing Cells Toward the beta-Cell Phenotype.
- Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. Full text available in PDF format. See also Insulin sensitivity gets a kick out of SOCS-7.
- The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy. See also Malfunctioning bone marrow cells sabotage nerve cells in diabetes.
- Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment. Free full text available in PDF format.
